Trends in Buprenorphine and Methadone Dispensing Among Medicare Advantage and Commercial Enrollees, 2019–2024

Hailemichael Bekele Shone, Jonathan Cantor, Kosali Simon, Erin A. Taylor

Open source

DOI
10.1016/j.focus.2026.100524
Published
2026-10
Container
AJPM Focus
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.focus.2026.100524,
  title = {Trends in Buprenorphine and Methadone Dispensing Among Medicare Advantage and Commercial Enrollees, 2019–2024},
  author = {Hailemichael Bekele Shone and Jonathan Cantor and Kosali Simon and Erin A. Taylor},
  year = {2026},
  journal = {AJPM Focus},
  doi = {10.1016/j.focus.2026.100524},
  url = {https://doi.org/10.1016/j.focus.2026.100524}
}

RIS

TY  - JOUR
TI  - Trends in Buprenorphine and Methadone Dispensing Among Medicare Advantage and Commercial Enrollees, 2019–2024
AU  - Hailemichael Bekele Shone
AU  - Jonathan Cantor
AU  - Kosali Simon
AU  - Erin A. Taylor
PY  - 2026
JO  - AJPM Focus
DO  - 10.1016/j.focus.2026.100524
UR  - https://doi.org/10.1016/j.focus.2026.100524
ER  - 

APA

Shone, H. B., Cantor, J., Simon, K., & Taylor, E. A. (2026). Trends in Buprenorphine and Methadone Dispensing Among Medicare Advantage and Commercial Enrollees, 2019–2024. AJPM Focus. https://doi.org/10.1016/j.focus.2026.100524

Source records